Company Overview and News
HOUSTON (Reuters) - Shares of U.S. oilfield service companies have fallen by more than 8 percent in the past month as worries about margins in the shale patch are clouding the sector’s nascent recovery.
FRAC GEC GE LBRT HK GNE PUMP HKRCP HK.WS
June 22, 2018: Markets opened higher Friday and the Dow appears on track to end an eight-day streak of closing in the red. The Nasdaq Composite has pulled back from an all-time high set earlier this week and is close to the break-even line. The energy sector jumped on news that OPEC is lifting production by less than expected has added some certainty for traders and investors. The tech sector was the day’s poorest performer.
GE GEC XOM WBA VZ GNE DWDP MCD VZA
General Electric’s (NYSE:GE) operating segment, GE Transportation, recently secured orders for 50 new locomotives from the Mexican and US rail subsidiaries of Kansas City Southern (NYSE:KSU). Notably, these locomotives are expected to be delivered by GE Transportation in 2019. Also, GE Transportation will offer digital solutions that would improve fuel and operational efficiency.
GE GEC FSS RAVN KSU.PR GNE KSU
June 22 (Reuters) - U.S. energy companies this week cut one oil rig, the first reduction in 12 weeks, after drillers started to slow down the rate of additions this month as pipeline constraints put a damper on future production.
BHI GEC GE GNE
On today’s episode of the Zacks Friday Finish Line, Associate Stock Strategist Ryan McQueeney and Editor Maddy Johnson take on this week’s biggest stories, including General Electric’s (GE - Free Report) departure from the Dow, Canada’s marijuana legalization vote, the new tax policies affecting Amazon (AMZN - Free Report) , and many more!
W FB GEC GE CMCSA GNE SBUX FINL EBAY
Investing solely for income, and finding the best dividend stocks, can be tricky. High dividend yields sound attractive on the surface, but almost always come with sharply higher risks. The largest risk is that the very same dividend will be cut. Those cuts usually have a doubled impact. They reduce — or eliminate — the income stream investors were buying in the first place. And as shareholders in companies like General Electric (NYSE:GE), Frontier Communications (NASDAQ:FTR) and Mattel (NASDAQ:MAT) have learned, they often coincide with steep declines in the share price as well.
GIS PG GOOG SBRA AMZN FTRPR GM.WS.A GM.WS.B GM.WS.C GM CVA SBRAP GE F GEC UPS WYNN FDX NYTAB MAT GOOGL TSLA GNE LVS GM.WSB FTR
(Reuters) - U.S. energy companies this week cut one oil rig, the first reduction in 12 weeks, after drillers started to slow down the rate of additions this month as pipeline constraints put a damper on future production.
BHI GEC GE GNE
June 22 (Reuters) - U.S. energy companies this week cut one oil rig, the first reduction in 12 weeks after drillers started to slow down the rate of additions this month as pipeline constraints put a damper on future production.
BHI GEC GE GNE
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), AbbVie (ABBV) and IBM (IBM). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
HD GEC GE MS.PRE MS.PRF MS.PRG MS.PRA ALK RHT ETR MS.PRI PEP MS.PRK GNE ABBV MS ABBV MCD
HOUSTON, June 22 (Reuters) - General Electric’s oilfield service firm Baker Hughes has laid off 266 workers in Schertz, Texas, according to a filing this month with the Texas Workforce Commission.
BHI GEC GE GNE
General Electric Company’s (GE - Free Report) operating segment, GE Transportation, recently secured orders for 50 new locomotives from the Mexican and US rail subsidiaries of Kansas City Southern (KSU - Free Report) . Notably, these locomotives are expected to be delivered by GE Transportation in 2019. Also, GE Transportation will offer digital solutions that would improve fuel and operational efficiency.
GEC GE FSS RAVN KSU.PR GNE KSU
2018-06-22 - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
2018-06-22 - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...
2018-06-18 - Asif
Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...
Silicon Investor Message Boards
This table lists all message boards related to LSE:GEC / GENERAL ELECTRIC CO. on message board site Silicon Investor.